Paper Details
- Home
- Paper Details
Original Abstract of the Article :
BACKGROUND: There are no systematic switching studies of antidepressants in the treatment of panic disorder. The present pilot study examined the usefulness of switching from imipramine to sertraline in 18 patients diagnosed with panic disorder with agoraphobia. METHOD: 15 patients who had had an u...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1097/00131746-200403000-00003
データ提供:米国国立医学図書館(NLM)
Switching Antidepressants for Panic Disorder: Imipramine to Sertraline
Panic disorder is a debilitating anxiety disorder that can significantly impact quality of life. This study examines the effectiveness of switching from imipramine to sertraline in patients with panic disorder with agoraphobia who had not responded adequately to imipramine treatment. The researchers followed 18 patients who were switched to sertraline, assessing their symptoms and response to treatment. Their results suggest that switching from imipramine to sertraline can be an effective strategy for patients who have not responded adequately to imipramine.
Switching Antidepressants: A Potential Solution for Panic Disorder
The study found that switching from imipramine to sertraline led to significant improvements in panic and phobic symptoms. These findings suggest that sertraline might be a more effective treatment option for some patients with panic disorder.
Navigating the Treatment Landscape for Panic Disorder
This research underscores the importance of finding the right treatment approach for panic disorder. The study's findings encourage further research into the optimal strategies for switching antidepressants, aiming to improve patient outcomes and minimize side effects.
Dr.Camel's Conclusion
Navigating the desert of panic disorder can be a daunting experience. This study offers valuable insights into the potential benefits of switching from imipramine to sertraline for those who have not responded adequately to imipramine. Continued research can help us find the most effective paths to recovery, ensuring a smoother and more successful journey through the desert of anxiety.
Date :
- Date Completed 2004-10-08
- Date Revised 2022-12-07
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.